West Pharma rises after raising annual forecasts - WST News | RalliesWest Pharma rises after raising annual forecasts
W
WST• West Pharmaceutical raises outlook after strong quarter
- Shares of medical equipment maker West Pharmaceutical (
WST.N) rise 7.3% to $384.5 premarket
- West Pharma now expects 2026 adjusted profit per share to be between $8.85 and $9.05, compared with its prior view of $8.40 to $8.75 per share
- Expects its annual sales to be in the range of $3.35 billion to $3.38 billion, up from its previous forecast of $3.295 billion to $3.35 billion
WST reports Q2 adjusted profit of $2.37 per share, above analysts' estimates of $2.08 per share - LSEG data- Its quarterly revenue came in at $872.3 million, above analysts' expectations of $838.6 million
- As of last close, stock was up 30.3% YTD
